منابع مشابه
Therapeutic vaccines for prostate cancer.
Prostate cancer is the most common, noncutaneous cancer for men in the U.S., leading to more than 30,000 deaths a year. Vaccines for prostate cancer, which for several years have been shown to generate immunologic responses, are beginning to show significant clinical promise. At present, numerous therapeutic options are being investigated, including autologous and allogeneic whole-tumor cell va...
متن کاملTherapeutic vaccines for ovarian cancer.
While therapeutic vaccines for ovarian cancer represent only a small fraction of active clinical trials, growing interest in this area and the accumulated data supporting the use of vaccines in cancer treatment portend further expansion of trials incorporating these strategies. This review explores the rationale for the use of vaccines for the treatment of ovarian cancer. It examines vaccine pl...
متن کاملTherapeutic cancer vaccines: an emerging treatment option.
Therapeutic cancer vaccines treat disease by stimulating the body's immune system. They are a form of active immunotherapy with the goal of producing an immune response that involves the cellular and humoral components of the immune system. These two components appear to be complementary and work together to induce tumor regression and long-lasting immunity to the disease being treated. This ar...
متن کاملTherapeutic Vaccines Against Cancer and Autoimmune Diseases
Elucidation of antigenicity and immunogenicity My laboratory pioneered the design of amino acid oligomers to define the minimal and precise chemical characteristics of antigens – molecules that could be bound by antibodies (1). Using these tools, we determined the functional size of the antibody binding pocket, and characterized the effects of charge, hydrophobicity, and side chain interactions...
متن کاملClinical trial designs for therapeutic cancer vaccines.
Therapeutic cancer vaccines have characteristics that require a new paradigm for phase I and phase II clinical development. Effective development plans may take advantage of some of the following observations: Dose ranging safety trials are not appropriate for many cancer vaccines. Dose ranging trials to establish an optimal biologic dose are often not practical. We have presented an efficient ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Therapeutics
سال: 2012
ISSN: 1075-2765
DOI: 10.1097/mjt.0b013e3182068cdb